4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
8.18
+0.08 (0.99%)
Nov 4, 2024, 4:00 PM EST - Market closed
4D Molecular Therapeutics Employees
4D Molecular Therapeutics had 147 employees as of December 31, 2023. The number of employees increased by 7 or 5.00% compared to the previous year.
Employees
147
Change (1Y)
7
Growth (1Y)
5.00%
Revenue / Employee
$137,537
Profits / Employee
-$747,571
Market Cap
424.85M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 147 | 7 | 5.00% |
Dec 31, 2022 | 140 | 16 | 12.90% |
Dec 31, 2021 | 124 | 41 | 49.40% |
Dec 31, 2020 | 83 | - | - |
Related Stocks
Company Name | Employees |
---|---|
GRAIL | 1,360 |
National Research | 435 |
Sangamo Therapeutics | 405 |
Esperion Therapeutics | 240 |
Butterfly Network | 225 |
Theravance Biopharma | 99 |
GH Research | 49 |
enGene Holdings | 33 |
FDMT News
- 18 hours ago - 4D Molecular Therapeutics Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Encourages Investor Participation - Accesswire
- 1 day ago - Shareholders Are Invited To Join The Schall Law Firm In An Inquiry Into 4D Molecular Therapeutics, Inc. For Securities Law Violations - Accesswire
- 2 days ago - 4D Molecular Therapeutics Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Investors To Reach Out - Accesswire
- 5 days ago - 4D Molecular Therapeutics Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Impacted Investors To Reach Out - Accesswire
- 7 days ago - 4D Molecular Therapeutics Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Investors To Take Part - Accesswire
- 8 days ago - Shareholders Are Encouraged To Join The Schall Law Firm In An Inquiry Into 4D Molecular Therapeutics, Inc. For Securities Law Violations - Accesswire
- 10 days ago - Shareholders Are Encouraged To Join An Inquiry Into 4D Molecular Therapeutics, Inc. For Securities Law Violations - Accesswire
- 17 days ago - The Schall Law Firm Encourages Investors To Help Investigate 4D Molecular Therapeutics Inc For Possible Securities Fraud - Accesswire